25021-129 : Ceftazidime 6 g/30ml Intravenous Injection, Powder, for Solution


NDC25021-129
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Ceftazidime
Dosage Form: Intravenous Injection, Powder, for Solution
Application #: ANDA062640
Rev. Date: 


NDC Package Codes:

  • 25021-129-69: 6 BOTTLE IN 1 CARTON (25021‑129‑69) > 30 ML IN 1 BOTTLE
  • 25021-129-99: 6 BOTTLE IN 1 CARTON (25021‑129‑99) > 30 ML IN 1 BOTTLE

Active Ingredients:

  • Ceftazidime

Dosage Strength:

  • 6 g/30mL

Pharmaceutical Classes:

  • Cephalosporin Antibacterial [EPC]
  • Cephalosporins [CS]

Related Products:

Based on records with the same trade name.
  • 25021-127 Ceftazidime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Sagent Pharmaceuticals
  • 25021-128 Ceftazidime 2 g/1 Intravenous Injection, Powder, for Solution by Sagent Pharmaceuticals
  • 0781-3177 Ceftazidime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Sandoz Inc
  • 0781-3178 Ceftazidime 2 g/1 Intravenous Injection, Powder, for Solution by Sandoz Inc
  • 0781-3179 Ceftazidime 200 mg/ml Intravenous Injection, Powder, for Solution by Sandoz Inc
  • 44567-235 Ceftazidime 1 g/20ml Intramuscular; Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-236 Ceftazidime 2 g/20ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-237 Ceftazidime 6 g/100ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-129 QR Code

< Prev: 25021-128Next: 25021-130 >

Related Discussions:

CEFTAZIDIME PRODUCT MONOGRAPH
PLEASE CEFTAZIDIME complete information as early as possible. ## Ceftazidime is usually reserved for the treatment of in... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 August 2015.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA